Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus can cause hair loss and nail changes, with treatments available for both.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

A 16-year-old boy with lupus had a rare brain artery issue but fully recovered with treatment.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Early diagnosis and quick treatment are crucial for severe lupus cases.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Histone modification is key in treating chronic inflammatory skin diseases.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Hair loss in lupus patients indicates higher disease activity.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Specialist nurses play a crucial role in managing lupus and empowering patients.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

A woman with lupus had right heart failure due to blood clots in her lungs, but treatment improved her condition.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.